THE EFFECT OF INITIAL AGE ON THE RESPONSE OF THE RAT TO TREATMENT WITH GONADOTROPHINS

1973 ◽  
Vol 72 (2) ◽  
pp. 209-217
Author(s):  
S. F. Lunn ◽  
J. A. Loraine

ABSTRACT In the rat, the age at which the maximum response to gonadotrophin treatment will occur is dependent on both the parameter being examined and the hormone, or combination of hormones used. Thus, the ovulation rate following treatment with pregnant mares' serum gonadotrophin (PMSG) alone, or in combination with human chorionic gonadotrophin (HCG), is maximal at an earlier age than that observed for HCG alone. From the data presented, it would seem that, for the conditions employed, the optimal age of animals for studies on gonadotrophin-induced ovulation would be approximately thirty days.

1991 ◽  
Vol 57 (1) ◽  
pp. 41-49 ◽  
Author(s):  
J. L. Spearow ◽  
R. P. Erickson ◽  
T. Edwards ◽  
L. Herbon

SummaryWe have examined the effects of major histocompatibility (H-2) haplotypes and genetic background (all loci other than the H-2 region) on hormone-induced ovulation rate in congenic strains of mice. In comparison with the H-2a haplotype, the H-2b haplotype increased hormone-induced ovulation rate 92% on the A/J (A) genetic background. However, H-2 haplotype did not affect hormone-induced ovulation rate on the C57BL/10J (C57) genetic background. The H-2b-linked gene(s) increased hormone-induced ovulation rate on the A/J genetic background largely by (1) enhancing the maturation of follicles in response to pregnant mare's serum gonadotrophin (PMSG) and (2) altering the stages of follicular development which can be induced to ovulate in response to human chorionic gonadotrophin (hCG). The observed effects of H-2 on hormone-induced ovulation rate were not explained by differences in the timing of puberty, the number of follicles present in untreated females, or the incidence of follicular atresia. The effect of genetic background on hormone-induced ovulation rate was much greater than was the effect of the H-2 region. We found that hormone-induced ovulation rate was five- to six-fold higher on the C57 genetic background than on the A genetic background. The C57 genetic background increased hormone-induced ovulation rate by (1) enhancing the induction of follicular maturation in response to gonadotropins and (2) by reducing the incidence of follicular atresia.


1976 ◽  
Vol 86 (1) ◽  
pp. 127-129 ◽  
Author(s):  
P. T. McGovern ◽  
J. A. Laing

Although the administration of pregnant mares' serum gonadotrophin (PMSG) to induce superovulation is a well established procedure (see Anderson, Schultz & Melampny, 1963), the unpredictability of the response to this treatment continues to impose a constraint on the commercial application of egg transfer techniques in the large domestic animals. In sheep, the additional use of human chorionic gonadotrophin (HCG) has been mainly centred on attempts to control the time of ovulation (Ortavant, Thibault & Wintenberger, 1949; Braden, Lamond & Radford, 1960; Dziuk et al. 1964; McGovern, Williams & Hancock, 1969). However, Killeen & Moore (1970) found that the proportion of follicles which rupture was increased in PMSG-treated ewes which had been given HCG at the beginning of oestrus. The purpose of the observations recorded here was to examine the possibility that a further gain in ovulation rate in PMSG-treated sheep might be obtained with the use of luteinizing hormone releasing factor (LHRF). No attempt was made to reproduce physiological levels of the releasing factor and dosage was aimed at achieving a superovulatory effect.


1999 ◽  
Vol 163 (2) ◽  
pp. 255-260 ◽  
Author(s):  
L Hinojosa ◽  
R Chavira ◽  
R Dominguez ◽  
P Rosas

The effects of thymulin administration beginning on days 19 or 24 of age on spontaneous puberty and gonadotrophin-induced ovulation were analysed in female normal and hypothymic mice. In normal and hypothymic mice, the daily administration of thymulin at 24 days of age resulted in a delay in the age of vaginal opening, with an increase in serum progesterone levels. Normal mice treated with 200 ng thymulin beginning on day 19 of age and injected with pregnant mare serum gonadotrophin (PMSG) 24 h later had an increase in ovulation rate, number of ova shed and weight of the ovaries. None of the hypothymic mice treated with thymulin on day 19 and PMSG on day 20 ovulated. PMSG treatment on day 25 induced ovulation in hypothymic mice. When these animals were injected previously with 200 ng thymulin, the number of ova shed by ovulating animals was lower than in PMSG-treated animals. Administration of thymulin and sequential injection of PMSG and human chorionic gonadotrophin 54 h later resulted in an increase in ovulatory response in comparison with those receiving only PMSG. The results suggest that thymulin plays a role in the regulation of spontaneous puberty through its effects on adrenal and ovarian endocrine functions. The increase in the ovarian PMSG response-treated animals, previously given thymulin, showed that this thymic hormone participates in the regulation of gonadotrophin secretion mechanisms and seems to be dose- and age-dependent. In hypothymic mice, neuroendocrine mechanisms regulating puberty are different from those of normal mice.


1981 ◽  
Vol 32 (1) ◽  
pp. 51-54 ◽  
Author(s):  
A. M. Paterson ◽  
D. R. Lindsay

ABSTRACTIn two experiments prepubertal gilts were injected with a combination of 400 international units pregnant mare's serum gonadotrophin and 200 international units human chorionic gonadotrophin. The gilts were housed either in contact with or isolated from mature boars. Data were obtained of ovarian activity determined immediately after gonadotrophin treatment and at the anticipated time of the second oestrus.All treated gilts ovulated in response to the treatment and 83% displayed oestrus. Ovulation rate varied both within and between experiments, in experiment 1 the range being 7 to 19 corpora lutea and in experiment 2, between 5 to >30 corpora lutea. Four distinct types of behaviour were observed at the time of the second cycle: ovulation associated with oestrus; ovulation without oestrus; oestrus but no ovulation; and a return to a prepubertal state with no oestrus or ovulation. The presence of boars enhanced the maintenance of cyclic activity. Overall, more gilts displayed a second oestrus (33/39 v. 19/41, X2 = 11·2, P<0·001), and more had a second ovulation (32/39 v. 24/41, X2=4·2, P<0·05) when boars were run with the gilts.


1984 ◽  
Vol 101 (3) ◽  
pp. 327-332 ◽  
Author(s):  
M. C. Richardson ◽  
G. M. Masson ◽  
M. R. Sairam

ABSTRACT The biological activity of deglycosylated human chorionic gonadotrophin (hCG) prepared by treatment of the native hormone with anhydrous hydrogen fluoride was evaluated using suspensions of dispersed cells from biopsies of human corpus luteum obtained during the luteal phase of normal menstrual cycles. A reproducible pattern of response to hCG in terms of progesterone production by luteal cells was established for a range of luteal ages. Deglycosylation of hCG led to a diminished level of maximum response to the hormone. Co-incubation of luteal cells with a level of hCG just sufficient to elicit a maximum response and increasing concentrations of deglycosylated hCG led to a progressive inhibition of the hormonal response; at a concentration of 103 ng deglycosylated hCG/ml (a tenfold excess of deglycosylated hCG over the native hormone), hCG-induced progesterone production was reduced by about 50%. Deglycosylated hCG therefore acts as a partial antagonist for the action of hCG on human luteal cells. J. Endocr. (1984) 101, 327–332


1991 ◽  
Vol 129 (3) ◽  
pp. 423-429 ◽  
Author(s):  
J. Th. J. Uilenbroek

ABSTRACT Administration of antiprogestagens (2 mg/day) to female rats for 21 days induces high serum prolactin levels. These levels stimulate luteal progesterone production and an increase in ovarian weight. Compared with RU486 (mifepristone) the increase in prolactin is less after treatment with ZK299 (onapristone), an antiprogestagen with lower antiglucocorticoid activity. To study whether cyclic ovulations occur in rats treated with antiprogestagens, 5-day cyclic rats were given daily injections of RU486 or ZK299 (2 mg) from metoestrus (day 1) to pro-oestrus. This treatment advanced the forthcoming ovulation by 1 day; however, the ovulation rate was low. Injection of 10 IU human chorionic gonadotrophin on the afternoon of pro-oestrus (day 3) increased the ovulation rate, but not to the level found in oil-treated rats. Serum LH concentrations measured from metoestrus to oestrus at 10.00 and 17.00 h were higher in antiprogestagen- than in oil-treated rats from day 2 (17.00 h) onwards. A low preovulatory LH surge was found in antiprogestagen-treated rats on the after-noon of pro-oestrus (day 3). Ovarian histology at the day of oestrus (day 4) confirmed the presence of a low LH surge as, besides ruptured follicles, unruptured follicles with dispersion of cumulus cells were present. The pro-oestrous surge of prolactin was also advanced by 24 h. The magnitude, however, was not different from that in oil-treated rats at day 4. In conclusion, daily administration of antiprogestagens to 5-day cyclic rats results in increased basal levels of serum LH and advancement of the preovulatory surge of prolactin and LH by 1 day. The ovulatory response is low due to the low pre-ovulatory surge of LH and to a reduced ability of preovulatory follicles to respond to LH. Journal of Endocrinology (1991) 129, 423–429


1960 ◽  
Vol 21 (2) ◽  
pp. 147-154 ◽  
Author(s):  
R. G. EDWARDS ◽  
RUTH E. FOWLER

SUMMARY The effects of an injection of pregnant mares' serum (PMS), human chorionic gonadotrophin (HCG), or of superovulation treatment with both of these gonadotrophins on subsequent reproductive behaviour of adult mice and on their response to a second superovulation treatment given shortly afterwards have been studied. An injection of PMS had induced ovulation, but not superovulation, in dioestrous mice autopsied 24 hr later. The injection also induced oestrus and superovulation in many mice (c. 30%) 60–62 hr later, a positive correlation being found between mating and ovulation in these mice. The resumption of the natural oestrous cycle after an injection of PMS was delayed in some of the mice. HCG had induced ovulation in mice in metoestrus-II and dioestrus autopsied 24 hr later. Most mice quickly resumed their natural oestrous cycle after the injection of HCG. If mice were not paired with males after the full superovulation treatment with PMS and HCG, they resumed their natural oestrous cycle within 3–6 days. Ovulation, fertilization and pregnancy during or after this natural oestrus were quite normal. These mice were also capable of further induced oestrus and superovulation when given a second course 1–3 days after the first treatment, though the number of mice that ovulated was lower, and the variability between mice in the number of eggs ovulated was higher, if the second treatment was given 1–2 days after the first. The corpora lutea formed in mice that mated after a superovulation treatment were fully active. A second treatment induced superovulation in most mice, but failed to induce oestrus in the majority of them, especially when given during mid-pseudopregnancy. Fertilization and embryonic development were quite normal in the few mice that mated.


Sign in / Sign up

Export Citation Format

Share Document